Hubert Tuyishime

Hubert Tuyishime

Auto-generated profile, based on publicly available information

Hubert Tuyishime

Stanford School of Medicine, Department of Orthopaedic Surgery, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2019 in Science
Verified
Journal Article
Open access
PDF file
PAPeter Abbink
Peter Abbink
NMNoe Bladimir Mercado
Noe Bladimir Mercado
JNJoseph P. Nkolola
Joseph P. Nkolola
RPRebecca L. Peterson
Rebecca L. Peterson
HTHubert Tuyishime
Hubert Tuyishime
DBDan H. Barouch
Dan H. Barouch
An antibody is not the antidote: An HIV therapeutic that would give long-term remission without sustained antiretroviral therapy (ART) is a long-term goal. Byrareddy et al. [ Science 354 , 197 (2016)] reported that treating simian immunodeficiency virus (SIV)–positive macaques with an antibody against integrin α 4 β 7 during and after ART results in sustained virologic control after stopping all treatment. Three studies in this issue question the reproducibility of that result. Di Mascio et al. sequenced the virus used in the 2016 study and found that it was a variant with a stop codon in the nef gene rather than a wild-type virus. Abbink et al. used the same antibody for α 4 β 7 as before but tested control of a more commonly used pathogenic virus. Iwamato et al. used the same nef -stop virus as in the earlier paper but combined the antibody against the integrin with an antibody against the SIV envelope glycoprotein, which also blocks viral binding of the integrin. None of these three new studies found that treating with the antibody had any effect on virologic control after stopping ART treatment. Science , this issue p. 1025 , p. 1029 , p. 1033

11 January 2022 in JCO Global Oncology
Verified
Journal Article
Open access
PHPaula Hornstein
Paula Hornstein
HTHubert Tuyishime
Hubert Tuyishime
Myriam MutebiMyriam Mutebi
Myriam Mutebi
NLNwamaka Lasebikan
Nwamaka Lasebikan
FRFidel Rubagumya
Fidel Rubagumya
TFTemidayo Fadelu
Temidayo Fadelu
PURPOSE: Authorship gender disparities persist across academic disciplines, including oncology. However, little is known about global variation in authorship gender distribution. METHODS: This retrospective cross-sectional study describes the distribution of author gender as determined from the first name across variables such as authorship position (first, middle, and last), country region, and country income level. The 608 articles with 5,302 authors included in this analysis were published in the Journal of Clinical Oncology Global Oncology, from its inception in October 2015 through March 2020. Primary outcome measure was author gender on the basis of first name probabilities assessed by genderize.io. World Bank classification was used to categorize the country region and income level. Odds ratios were used to describe associations between female last authorship and representation in other authorship positions. RESULTS: Although female authors were in the minority across all authorship positions, they were more under-represented in the last author position with 190 (32.1%) female, compared with 252 (41.4%) female first authors and 1,564 (38.1%) female middle authors. Female authors were most under-represented among authors from low-income countries, where they made up 21.6% of first authors and 9.1% of last authors. Of all the regions, sub-Saharan Africa and South Asia had the lowest percentage of female authors. Compared with articles with male last authors, those with female last authors had odds ratios (95% CI) of 2.2 (1.6 to 3.2) of having female first authors and 1.4 (0.9 to 2.1) of having 50% or more female middle authors. CONCLUSION: There are wide regional variations in author gender distribution in global oncology. Female authors remain markedly under-represented, especially in lower-income countries, sub-Saharan Africa, and South Asia. Future interventions should be tailored to mitigate these disparities.

13 June 2022 in JCO Global Oncology
Verified
Journal Article
Open access
HTHubert Tuyishime
Hubert Tuyishime
PHPaula Hornstein
Paula Hornstein
NLNwamaka Lasebikan
Nwamaka Lasebikan
FRFidel Rubagumya
Fidel Rubagumya
Myriam MutebiMyriam Mutebi
Myriam Mutebi
TFTemidayo Fadelu
Temidayo Fadelu
PURPOSE: Local researchers must be engaged in research conducted in their populations. However, local authors from low- and middle-income countries are often under-represented in global health journals. This report aims to assess and describe the representation of authors in the Journal of Clinical Oncology Global Oncology ( JCO GO). METHODS: This retrospective cross-sectional study describes data from JCO GO articles published between October 2015 and March 2020. Data were collected on studied countries, authorship position, classified as first, middle, or last, and country of authors' institutional affiliations. Countries were then categorized on the basis of their World Bank region and income classifications. We describe aggregate authorship distribution and distribution by region and income classification. Additionally, we explore the relationships between author's country and studied country. RESULTS: Of the 608 articles identified, 420 (69.1%) studied a single country population. Although articles represented studies from all World Bank regions, the sub-Saharan Africa (SSA) region accounted for the highest number (n = 145; 34.5%). In all other regions except SSA, most of the first (66.7%-100%) and last authors (56.6%-95.2%) had primary institutional affiliations based in the same region as the studied country. However, among articles about SSA countries, SSA first authors (n = 65; 44.8%) and last authors (n = 59; 40.7%) were under-represented. In fact, there were more North American first (n = 74; 51.0%) and last authors (n = 72; 49.6%) than SSA authors. There was higher SSA representation among middle authors (n = 97; 68.8%) in studies from the region. A similar trend was also noted with the under-representation of authors from low-income compared with high-income countries. CONCLUSION: SSA authors are under-represented in global oncology articles. Concerted strategies are needed to build local capacity, promote meaningful engagement, and foster equity.

4 April 2025 in The Oncologist
Verified
Journal Article
Open access
RDRebecca J DeBoer
Rebecca J DeBoer
CWChiara A Wabl
Chiara A Wabl
BMBeatrice P Mushi
Beatrice P Mushi
PUPacifique Uwamahoro
Pacifique Uwamahoro
RARaymond Athanas
Raymond Athanas
VCVincent K Cubaka
Vincent K Cubaka
Background: Cancer care involves disclosing difficult information, making treatment decisions, and advance care planning. Communication practices and preferences are strongly influenced by sociocultural context. This scoping review aims to identify, map, and appraise the available evidence on clinical communication in cancer care in Africa and recommend priorities for future work. Methods: A search strategy was developed to identify studies conducted in Africa with a primary focus on patient-clinician communication in cancer care and performed in PubMed, Embase, Web of Science, CINAHL, African Index Medicus, and PsycINFO. Two reviewers independently screened titles and abstracts, full texts, and cited references. Study characteristics were analyzed using descriptive statistics and content analysis. Critical appraisal was performed using the Mixed Methods Appraisal Tool. Results: Our search yielded 58 articles from 19 countries. Study designs were quantitative survey (53%), qualitative (38%), non-randomized experimental (5%), and mixed methods (3%), with no randomized trials. Populations included patients with cancer (n = 25), doctors (n = 24), nurses (n = 16), family/caregivers (n = 16), and/or others. Seven studies (12%) focused on pediatrics. Most studies (60%) focused on clinicians’ disclosure of information, often framed as “breaking bad news” or “truth-telling.” The remainder focused on information preferences (14%), advance care planning (10%), illness understanding (5%), shared decision making (5%), and communication training (3%). Critical appraisal demonstrated higher quality among qualitative than quantitative studies. Conclusions: Future work should explore underexamined research areas such as patient-centered communication, translate observational findings into intervention development and testing, implement communication skills training, and evaluate outcomes related to communication in cancer care in Africa.

21 April 2024 in Journal of Hand Surgery Global Online
Verified
Journal Article
Open access
JZJoanne Y. Zhou
Joanne Y. Zhou
HTHubert Tuyishime
Hubert Tuyishime
JYJeffrey Yao
Jeffrey Yao
Triangular fibrocartilage complex (TFCC) injuries are a common cause of ulnar-side wrist pain and may progress to persistent pain, instability of the distal radioulnar joint, and arthritis if left untreated. Diagnosis and management of these injuries requires a nuanced understanding of features pertinent to the clinical presentation, imaging, and arthroscopic findings for accurate management. Arthroscopic-assisted repair techniques have revolutionized surgical management, providing detailed visualization and facilitating the repair of TFCC injuries and associated pathologies with minimally invasive techniques. In this review, we discuss the anatomy of the TFCC, history and examination of ulnar-sided pathology, imaging findings, and classification schemes and review surgical techniques for the treatment of TFCC injuries. We also touch on pearls and pitfalls of the techniques, complications, and results of treatment.

1 May 2024 in The Joint Commission Journal on Quality and Patient Safety
Verified
Journal Article
Closed access
HTHubert Tuyishime
Hubert Tuyishime
RCRebecca Claure
Rebecca Claure
KBKarthik Balakrishnan
Karthik Balakrishnan
HCHeidi Chan
Heidi Chan
LLLinda Lam
Linda Lam
KSKevin Shea
Kevin Shea